WebApr 11, 2024 · View CRSP analyst ratings or view top-rated stocks. What is CRISPR Therapeutics' stock price forecast for 2024? 18 Wall Street analysts have issued 12-month price objectives for CRISPR … Web23 hours ago · Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024. The company...
CRISPR Therapeutics Is an Interesting
Web20 hours ago · Cathie Wood Buys CRSP Stock Before Cantor Price Target Initiation Cantor analyst Olivia Brayer has initiated coverage of Crispr with an “overweight” rating and a … Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not … january 1 is what national day
CRISPR Therapeutics AG Common Shares (CRSP) Analyst Research
WebApr 13, 2024 · Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, CRISPR Therapeutics has a consensus rating of “Hold” and a consensus target price of $72.84. CRISPR Therapeutics Profile ( Get Rating) Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. The average price target for CRSP is $87.24 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CRSP a Buy today. Find out what this means to you and get the rest … january 1 new year\\u0027s day